Texas 2017 85th Regular

Texas House Bill HB2830 Introduced / Fiscal Note

Filed 02/02/2025

Download
.pdf .doc .html
                    LEGISLATIVE BUDGET BOARD    Austin, Texas      FISCAL NOTE, 85TH LEGISLATIVE REGULAR SESSION            April 7, 2017      TO: Honorable René Oliveira, Chair, House Committee on Business & Industry      FROM: Ursula Parks, Director, Legislative Budget Board     IN RE:HB2830 by Oliveira (Relating to the closed formulary for workers' compensation pharmaceutical benefits.), As Introduced    No significant fiscal implication to the State is anticipated.  The bill would amend the Labor Code relating to the closed formulary for workers' compensation pharmaceutical benefits. Based on information provided by the Texas Department of Insurance, State Office of Risk Management, Texas Department of Transportation, The University of Texas System Administration, and Texas A&M University System Administration, this analysis assumes the duties and responsibilities associated with implementing the provisions of the bill could be accomplished by utilizing existing resources. Local Government Impact No significant fiscal implication to units of local government is anticipated.    Source Agencies:454 Department of Insurance, 479 State Office of Risk Management, 601 Department of Transportation, 710 Texas A&M University System Administrative and General Offices, 720 The University of Texas System Administration   LBB Staff:  UP, CL, CP    

LEGISLATIVE BUDGET BOARD
Austin, Texas
FISCAL NOTE, 85TH LEGISLATIVE REGULAR SESSION
April 7, 2017





  TO: Honorable René Oliveira, Chair, House Committee on Business & Industry      FROM: Ursula Parks, Director, Legislative Budget Board     IN RE:HB2830 by Oliveira (Relating to the closed formulary for workers' compensation pharmaceutical benefits.), As Introduced  

TO: Honorable René Oliveira, Chair, House Committee on Business & Industry
FROM: Ursula Parks, Director, Legislative Budget Board
IN RE: HB2830 by Oliveira (Relating to the closed formulary for workers' compensation pharmaceutical benefits.), As Introduced

 Honorable René Oliveira, Chair, House Committee on Business & Industry 

 Honorable René Oliveira, Chair, House Committee on Business & Industry 

 Ursula Parks, Director, Legislative Budget Board

 Ursula Parks, Director, Legislative Budget Board

HB2830 by Oliveira (Relating to the closed formulary for workers' compensation pharmaceutical benefits.), As Introduced

HB2830 by Oliveira (Relating to the closed formulary for workers' compensation pharmaceutical benefits.), As Introduced



No significant fiscal implication to the State is anticipated.

No significant fiscal implication to the State is anticipated.



The bill would amend the Labor Code relating to the closed formulary for workers' compensation pharmaceutical benefits. Based on information provided by the Texas Department of Insurance, State Office of Risk Management, Texas Department of Transportation, The University of Texas System Administration, and Texas A&M University System Administration, this analysis assumes the duties and responsibilities associated with implementing the provisions of the bill could be accomplished by utilizing existing resources.

Local Government Impact

No significant fiscal implication to units of local government is anticipated.

Source Agencies: 454 Department of Insurance, 479 State Office of Risk Management, 601 Department of Transportation, 710 Texas A&M University System Administrative and General Offices, 720 The University of Texas System Administration

454 Department of Insurance, 479 State Office of Risk Management, 601 Department of Transportation, 710 Texas A&M University System Administrative and General Offices, 720 The University of Texas System Administration

LBB Staff: UP, CL, CP

 UP, CL, CP